Stocks in action: Air Canada, BioNTech, Lululemon, Bombardier

Here is a selection of announcements that have moved (or will move) the prices of these companies:

(Come back to read us from time to time
so as not to miss an update)

Air Canada

In its outlook for this year, Air Canada (AC.TO, $24.62) says its capacity for 2022, measured in available seats, will be up about 150% from last year. However, it says its capacity will still only be around 75% of what it was in 2019 as it continues to accommodate passenger demand, public health guidelines and travel restrictions.

The airline says it expects its adjusted cost per available seat mile for 2022 to increase about 13-15% from 2019. Looking further into the future, Air Canada says it expects that its capacity for 2024 will be around 95% of its 2019 level.

Air Canada CEO Michael Rousseau said that with the pandemic receding and travel returning, the airline has put in place a strategy to return to profitability and increase long-term shareholder value. .


The German pharmaceutical company BioNTech (BNTX, US$172.39), the originator of the first messenger RNA vaccine against COVID-19 with Pfizer, saw its net profit explode in 2021 to 10 billion euros, after a result of 15 million l previous year, the first profit in its history. The young company had still recorded a loss of some 180 million euros in 2019.

The BioNTech/Pfizer vaccine has been a game-changer since it got the green light from regulators in late 2020, the first authorization for a COVID vaccine in the European Union and the United States. A total of 3.1 billion doses were delivered by the Mainz-based laboratory, which has become a major player in the pharmaceutical industry.

The rise of the small biotech company has had a measurable impact on the German economy, with economists estimating that it contributed ‘around 0.5%’ to national growth in 2021. The group paid 4.8 billion euros in taxes. The company’s turnover reached 19 billion euros over the year, compared to 482 million in 2020.

The company plans to invest between 1.4 and 1.5 billion euros in research and development this year, or 50% more than in 2021, with growth still expected in the “following years”. The German laboratory is working on vaccines against malaria, shingles, tuberculosis and certain cancers.

BioNTech expects 2022 revenues between 13 and 17 billion euros related to the vaccine against COVID.


lululemon Athletics (LULU, US$3,443.97) posted fourth-quarter profit up nearly 32% on Tuesday, capping a fiscal year that saw its annual revenue top the US$6 billion mark for the first time . The Vancouver-based exercise apparel retailer raked in a profit of US$434.5 million, or US$3.36 per share, for its most recent quarter, up from US$329.8 million, or US$2.52 per share, from the same period a year earlier.

Adjusted earnings for the three months ended Jan. 30 were US$3.37 per share, up from US$2.58 per share in the fourth quarter of 2020. Revenue increased 23% to US$2.13 billion, compared to US$1.73 billion a year earlier. Sales of stores open for at least a year advanced 32% and online sales gained 17%, this time representing 49% of the company’s total revenue.

Analysts on average had expected adjusted earnings per share of US$3.28 on revenue of US$2.14 billion, according to financial data firm Refinitiv. For the full year, Lululemon earned US$975.3 million from revenue of US$6.26 billion. Last year, profit was US$588.9 million and revenue was US$4.4 billion.

In the most recent quarter, Lululemon opened 22 new company-operated stores, bringing its total number of locations to 574.


The Global 7500 program of Bomber (BBD-B.TO, $1.50) marked a symbolic milestone with the delivery of the hundredth device. The Montreal business jet manufacturer held an event on Tuesday at its Dorval facilities with its client VistaJet to mark the achievement of this target.

The event was an opportunity for Bombardier to promote the progress of its strategy, which since 2020 has focused solely on business jets. In a press briefing, the president and chief executive officer, Éric Martel, underlined that all the aircraft delivered by Bombardier were profitable. At the end of February, the company reiterated its intention to reach annual revenues of US$7.5 billion by 2025 during an investor presentation.

Bombardier began development of the Global family in 1993 with the Global Express business jet, which entered service in 1999. The Global 7500 program, for its part, was launched in 2010. The first deliveries took December 2018. In December, the company held a similar event to mark the delivery of its 1,000th Global family aircraft.

About the author


Leave a Comment